Accellacare UK Limited
Other human health activities · Berkshire · incorporated 2000
Is this your company? Claim this profile ›
How it compares
Accellacare UK Limited against its county.
Turnover for the 20 largest companies we track in Berkshire, from their filed accounts.
Industry context
Other human health activities
SIC 86900
- Active UK companies
- 433
- Median turnover
- £340,514
- Sector risk grade
- A-
County at a glance
- Top 20 combined turnover
- £635m
- Average per company
- £31.8m
- This company vs average
- 0.3×
Filing timeline
On time, on the record.
Key dates from the Companies House register.
Incorporated
10 Nov 2000
Accounts made up to
31 Dec 2024
Latest filing: Confirmation statement
25 Mar 2026
Next accounts due
30 Sep 2026
Online presence
Digital score: Emerging
Our 0–1 score for how established and consistent a company's online presence is, compared with the Berkshire average.
- This company 0.02
- County average 0.23
Analysis
What the filings tell us.
Introduction
Accellacare UK Limited operates within the Berkshire commercial ecosystem as a notable entity currently classified as having Emerging digital strength. Registered under the official Companies House framework, the firm holds a regional position of sixteenth out of twenty monitored entities. This ranking places the company in the lower tier of local participants, suggesting a consolidated operational model that prioritizes core output over aggressive regional market expansion. Understanding the standing of Accellacare UK Limited Companies House filings is essential for stakeholders seeking to contextualize the firm within the broader competitive landscape of the county.
Regional Footprint
The economic contribution of Accellacare UK Limited is reflected in its annual turnover of 8.8 million pounds, which constitutes 1.4 percent of the aggregate 635.3 million pounds generated by monitored businesses in the area. While this turnover volume suggests a stable mid-tier operational capacity, it also indicates a niche role within the Berkshire supply chain. Given this level of financial performance, the company likely supports a modest but specialized employment tier. For Archive Partners Berkshire monitoring, this scale warrants a focus on how local operational shifts may influence the wider regional economic output.
Digital Benchmark
The classification of the firm as Emerging reflects a digital footprint that sits significantly below the regional average. With a digital score trailing the county benchmark by over ninety percent, the firm presents a unique profile for procurement teams and credit analysts. Such a disparity in digital engagement often indicates a reliance on traditional business-to-business relationship management rather than public-facing discovery platforms. For ESG auditors and compliance officers, this gap suggests a lower degree of digital maturity, necessitating deeper scrutiny of data transparency and the firm’s overall approach to modern regulatory posture in a competitive market.
Financial Health Signals
Financial governance is best assessed through the cadence of iXBRL filings, which provide a window into the institutional discipline of the firm. By evaluating the Berkshire business financial performance against SIC-peer benchmarks, we can discern whether the current turnover reflects steady state operations or a period of underlying volatility. With only ten indexed search signals, the data visibility surrounding the entity remains relatively low, which typically correlates with increased opacity. At Archive Partners, we track these signals to differentiate between private stability and potential informational gaps that could pose risks to external stakeholders or credit providers.
Watchlist Signals
Subscribers should maintain rigorous oversight of Accellacare UK Limited by monitoring director change events and strict adherence to statutory filing deadlines. Because the digital footprint remains in the early stages, any rapid shift in search signal trajectory or changes in the Berkshire company digital compliance profile should be treated as a key intelligence trigger. Fund analysts and procurement leads should prioritize the velocity of regulatory disclosures to ensure that the current risk profile remains consistent. Monitoring these specific indicators allows for proactive risk mitigation before broader financial or operational trends manifest in public performance data.
Market Outlook
Over the next twelve to twenty-four months, the company faces a challenging environment defined by the economic trajectories of the Berkshire sector. Given the firm’s current ranking and turnover, management must navigate potential headwinds related to operational scaling and capital allocation. The most critical factor for stakeholders will be the firm’s ability to improve transparency metrics in the upcoming filing cycle. Investors should weight the stability of existing contracts against the potential for digital modernization. We recommend a cautious stance, focusing on consistent financial disclosure as the primary indicator of long-term commercial health and resilience.
All data is based on the latest digital audit and is subject to change without notice. Rankings and scores are updated periodically as new regulatory and web intelligence signals are processed. To report a data discrepancy, please contact our support team.
Claim this profile to manage Accellacare UK Limited’s compliance record, respond to signals, and add verified contact details.
Written with AI assistance from filed data and our scores. Check key facts against the company record.
For developers
This whole profile, in one API call.
Pull the same record, scores and analysis into your CRM, spreadsheet or app. Add only the fields you need.
GET https://api.archive.partners/v1/marketintel/benchmark/companies/04105540?fields[]=introduction&fields[]=financial_health_signals&fields[]=market_outlook{
"company_id": "04105540",
"company_name": "Accellacare UK Limited",
"county": "Berkshire",
"county_rank": 16,
"turnover_millions": 8.83,
"postcode": "RG2 6GP",
"fields": {
"introduction": "Accellacare UK Limited operates within the Berkshire commercial ecosystem as a notable entity currently cla...",
"financial_health_signals": "Financial governance is best assessed through the cadence of iXBRL filings, which provide a window into the...",
"market_outlook": "Over the next twelve to twenty-four months, the company faces a challenging environment defined by the econ..."
}
}All six analysis sections are available as fields. Add only the ones you need.
Related companies
Other human health activities: 2026 industry report (SIC 86900) ›
Stay ahead
Watch Accellacare UK Limited, and companies like it.
Get an alert when they file accounts, cross a threshold or change directors.